Literature DB >> 35319072

Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onset.

Yoshio Araki1, Takashi Mamiya2, Naotoshi Fujita3, Kenji Uda2, Kinya Yokoyama2, Fumiaki Kanamori2, Kai Takayanagi2, Kazuki Ishii2, Masahiro Nishihori2, Kazuhito Takeuch2, Kuniaki Tanahashi2, Yuichi Nagata2, Yusuke Nishimura2, Takafumi Tanei2, Masaki Sumitomo4, Sho Okamoto5, Takashi Izumi2, Katsuhiko Kato6, Ryuta Saito2.   

Abstract

The purpose of this study was to examine the effects of combined revascularization for ischaemic-onset moyamoya disease (MMD) on cerebral haemodynamics by comparing cerebral blood flow (CBF) during the postoperative chronic phase with preoperative CBF. A retrospective cohort of 24 MMD patients (representing 31 surgeries) who received single photon emission computed tomography (SPECT) before and more than 6 months after surgery was investigated. The CBF value of each vascular territory was extracted from SPECT data, and the value relative to the ipsilateral cerebellar value (relative CBF, or RCBF) was calculated. The correlation between the revascularization effect and the proportional change in RCBF before and after surgery (calculated as post-RCBF/pre-RCBF ("post/pre-RCBF")) was analysed. Furthermore, the relationships between changes in neurological symptoms and post/pre-RCBF were investigated. Preoperative and postoperative mean RCBF values were 0.92 ± 0.15 and 0.96 ± 0.13 (p = 0.619) in the anterior cerebral artery territory, 0.99 ± 0.17 and 1.01 ± 0.17 (p = 0.598) in the middle cerebral artery territory and 1.15 ± 0.22 and 1.14 ± 0.19 (p = 0.062) in the posterior cerebral artery territory, respectively. No significant correlation was found between the revascularization score and post/pre-RCBF. The revascularization score and post/pre-RCBF were not significant predictors of worsening neurological symptoms postoperatively. No significant change in RCBF was observed in any vascular territory in the chronic phase after revascularization. Combined revascularization may assist in the redirection of blood flow from the internal to the external carotid system and contribute to CBF maintenance.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cerebral blood flow; Combined revascularization surgeries; Moyamoya disease; Postoperative chronic phase; SPECT

Year:  2022        PMID: 35319072     DOI: 10.1007/s10143-022-01774-8

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  18 in total

Review 1.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

2.  Cognitive function of patients with adult moyamoya disease.

Authors:  Yoshio Araki; Yasushi Takagi; Keita Ueda; Shiho Ubukata; Junko Ishida; Takeshi Funaki; Takayuki Kikuchi; Jun C Takahashi; Toshiya Murai; Susumu Miyamoto
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-06-21       Impact factor: 2.136

3.  Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis.

Authors:  Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Michihiro Kurimoto; Yoshiki Shiba; Takashi Mamiya; Masahiro Nishihori; Takashi Izumi; Masaki Sumitomo; Sho Okamoto; Kota Matsui; Ryo Emoto; Toshihiko Wakabayashi; Shigeyuki Matsui; Atsushi Natsume
Journal:  Neurosurg Rev       Date:  2021-01-08       Impact factor: 3.042

4.  Surgical Designs of Revascularization for Moyamoya Disease: 15 Years of Experience in a Single Center.

Authors:  Yoshio Araki; Kenji Uda; Kinya Yokoyama; Fumiaki Kanamori; Takashi Mamiya; Masahiro Nishihori; Takashi Izumi; Kuniaki Tanahashi; Masaki Sumitomo; Sho Okamoto; Toshihiko Wakabayashi; Atsushi Natsume
Journal:  World Neurosurg       Date:  2020-04-13       Impact factor: 2.104

5.  Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.

Authors:  Miki Fujimura; Hiroaki Shimizu; Takashi Inoue; Shunji Mugikura; Atsushi Saito; Teiji Tominaga
Journal:  Neurosurgery       Date:  2011-04       Impact factor: 4.654

6.  Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Shunji Mugikura; Hiroaki Shimizu; Teiji Tominaga
Journal:  Surg Neurol       Date:  2007-03

7.  Symptomatic cerebral hyperperfusion on SPECT after indirect revascularization surgery for Moyamoya disease.

Authors:  Won-Sang Cho; Ho-Young Lee; Hyun-Seung Kang; Jeong Eun Kim; Jae Seung Bang; Chang-Wan Oh
Journal:  Clin Nucl Med       Date:  2013-01       Impact factor: 7.794

8.  How does angiogenesis develop in pediatric moyamoya disease after surgery? A prospective study with MR angiography.

Authors:  Kiyohiro Houkin; Naoki Nakayama; Satoshi Kuroda; Tatsuya Ishikawa; Tadashi Nonaka
Journal:  Childs Nerv Syst       Date:  2004-10       Impact factor: 1.475

9.  Age-dependent revascularization patterns in the treatment of moyamoya disease in a European patient population.

Authors:  Marcus Czabanka; Peter Vajkoczy; Peter Schmiedek; Peter Horn
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

10.  Cerebral Hemodynamic Changes After Revascularization in Patients With Hemorrhagic Moyamoya Disease.

Authors:  Kaijiang Kang; Ning Ma; Jinxin Li; Yuan Shen; Weibin Gu; Guofeng Ma; Dong Zhang; Xingquan Zhao
Journal:  Front Neurol       Date:  2020-02-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.